SINGAPORE, March 24, 2024 /PRNewswire/ — Juniper Biologics (“Juniper”), Singapore-based science-led pharmaceutical company focused on researching, developing, and commercializing novel therapies, celebrates another milestone as it received the award for Best Novel Therapy R&D and…

TOKYO, March 24, 2024 /PRNewswire/ — TIER IV, a pioneer in open-source autonomous driving (AD) technology, is proud to announce its selection in the Japan Aerospace Exploration Agency (JAXA) Space Exploration Innovation Hub’s 11th “Open Innovation Hub for Expanding Humanosphere and…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.